Recent studies statistically showed elevated expression of TNFR2 in 25 types of tumors, including renal cancer, multiple myeloma, ovarian cancer, colon cancer, and cutaneous T-cell lymphoma [8]. This evidence concerns the gene TNFRSF1B and plasma cell myeloma.